4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-20-030611
President & CSO sold 15,000 shares at an average $19.32 ($289,841)
- President & CSO acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Shacham Sharon · President & CSO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-05-15 | Exercise or conversion : show line 1 in the form | +7,500 | $0.03 | $248 | 763,989 | D |
| 2020-05-15 | Sale : show line 2 in the form | −7,500 | $18.65 | $139,841 | 756,489 | D |
| 2020-05-18 | Exercise or conversion : show line 3 in the form | +7,500 | $0.03 | $248 | 763,989 | D |
| 2020-05-18 | Sale : show line 4 in the form | −7,500 | $20.00 | $150,000 | 756,489 | D |
| Open-market sales · 15,000 sh · avg $19.32 · $289,841 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-05-15 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −7,500 | $0.03 | 2020-10-21 | 7,500 | 7,857 | D |
| 2020-05-18 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −7,500 | $0.03 | 2020-10-21 | 7,500 | 357 | D |
Loading xslF345X03/doc4.xml…